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Abstract
BACKGROUND—This study evaluated whether there is an association between maternal 
occupational exposure to polycyclic aromatic hydrocarbons (PAHs) and neural tube defects 
(NTDs) in offspring. This is the first such study of which the authors are aware.
METHODS—Data were analyzed from 1997 to 2002 deliveries in the National Birth Defects 
Prevention Study, a large population-based case-control study in the United States. Maternal 
interviews yielded information on jobs held in the month before through 3 months after 
conception. Three industrial hygienists blinded to case or control status assessed occupational 
exposure to PAHs. Crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were 
estimated using unconditional logistic regression.
RESULTS—Of the 520 mothers of children with NTDs, 5.0% were classified as exposed to 
occupational PAHs, as were 3.5% of the 2989 mothers of controls. The crude OR for PAH 
exposure was 1.43 (95% CI, 0.92–2.22) for any NTD and 1.71 (95% CI, 1.03–2.83) for spina 
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bifida. Adjusted ORs were smaller in magnitude and not significant. Among women who were 
normal weight or underweight, the crude OR for spina bifida was 3.13 (95% CI, 1.63–6.03) and 
adjusted OR was 2.59 (95% CI, 1.32–5.07). Based on estimated cumulative exposure, a 
statistically significant dose-response trend was observed for spina bifida; however, it was 
attenuated and no longer significant after adjustment.
CONCLUSION—Maternal occupational exposure to PAHs may be associated with increased risk 
of spina bifida in offspring among women who are normal weight or underweight. Other 
comparisons between PAHs and NTDs were consistent with no association.
Keywords
PAHs; polycyclic aromatic hydrocarbons; occupation; maternal exposure; malformations; neural 
tube defects; spina bifida
INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are lipophilic compounds formed during the 
incomplete burning of coal, tobacco, or other organic substances. Human exposure is 
common, through inhalation of tobacco smoke, smoke from other sources of combustion, 
and ambient air, and through consumption of PAHs particularly in charbroiled foods. 
Although environmental sources are important, some of the highest exposure levels are 
found in the workplace (Brandt and Watson, 2003; Hansen et al., 2008). Occupations where 
exposure is likely to occur are those involving coke ovens and coal tar use, iron and steel 
works, aluminum works, foundries, carbon electrode and carbon black manufacture, and 
asphalt manufacture and use. In addition, exposures can occur in more common 
occupational settings such as restaurants (Sjaastad and Svendsen, 2009).
Maternal exposure to PAHs has been shown in laboratory animals to cause neural tube 
defects (NTDs), birth defects affecting the brain and spinal cord that arise from failure of the 
embryonic neural tube to close in the first month of pregnancy. This effect can vary 
depending on the genotype of the fetus and mother, on the specific type of PAH, and on the 
route of exposure (Faustman-Watts et al., 1984; Barbieri et al., 1986; Stark et al., 1989; 
Incardona et al., 2004). Four human studies have indicated a positive association between 
maternal exposure to PAHs and the risk of NTDs using residence location or biomarkers of 
exposure (Dodds and Seviour, 2001; Rankin et al., 2009; Naufal et al., 2010; Ren et al., 
2011). However, no study has assessed maternal occupational exposure to PAHs and risk of 
NTDs in offspring.
Because of the high and potentially common workplace exposures to PAHs and evidence 
suggesting an association of PAHs and NTDs, the objective of this study was to determine 
whether women's periconceptional occupational exposure to PAHs was associated with risk 
of NTDs in offspring.
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This analysis used data from the National Birth Defects Prevention Study (NBDPS), an 
ongoing, population-based, case-control study of more than 30 major structural birth defects. 
Detailed study methods have been published elsewhere (Yoon et al., 2001). Case infants 
were ascertained from birth defects surveillance systems in eight sites: Arkansas, California, 
Georgia (Centers for Disease Control and Prevention), Iowa, Massachusetts, New Jersey, 
New York, and Texas. Infants having or strongly suspected to have a chromosome 
abnormality or single-gene condition were excluded. Cases were reviewed by a clinical 
geneticist at each site before inclusion to ensure that case definitions were met (Rasmussen 
et al., 2003). Cases were live births from all sites, fetal deaths from all sites except New 
Jersey and New York, and pregnancy terminations from all sites except New Jersey, New 
York, and Massachusetts. Control infants were live born, without birth defects, and were 
selected at random from birth certificates or birth hospital records from the same populations 
that provided the cases. All mothers participated in a computer-assisted telephone interview 
(CATI) in English or Spanish, from 6 weeks through 24 months after their estimated due 
dates. Mothers were asked questions on a variety of topics including maternal illnesses and 
medication use, pregnancy history, diet, vitamin intake, tobacco use, alcohol intake, 
substance use, and information about jobs held during preconception and pregnancy. The 
NBDPS was approved by the Office of Management and Budget at the Centers for Disease 
Control and Prevention and the appropriate institutional review boards at each participating 
site.
This analysis included mothers of cases with NTDs (anencephaly, craniorachischisis, spina 
bifida, and encephalocele) and control infants with estimated dates of delivery from October 
1, 1997, through December 31, 2002. Mothers also had to have completed interviews and to 
have worked at least one job for at least 1 month, from 1 month before conception through 3 
months after (defined here as the periconceptional period). There were no inclusion criteria 
based on minimum number of hours worked per week, but six women who could not be 
assigned PAH exposure status (described later) were excluded. The resulting study 
population consisted of 2989 controls and 520 cases of NTDs composed of 136 cases of 
anencephaly, 321 cases of spina bifida, and 63 cases of encephalocele.
Exposure Assessment
In the CATI, the first occupational question was: “The next section is a series of questions 
about your work experiences—paid, volunteer, or military service. This includes part-time 
and full-time jobs, jobs at home, and jobs on a farm or outside your home that lasted 1 
month or more. Between (3 months before conception) and (date of infant birth), did you 
have a job?” For each job, the mother was asked to provide the employer name, job title, 
descriptions of the company's product or service, main job activities and duties, chemicals or 
substances handled, and machines used on the job. Mothers also provided job start and end 
dates and quantitative information on the usual number of days worked per week and hours 
worked per day. Each job was coded for occupation and industry using the 2000 Standard 
Occupational Classification (SOC) System (United States Department of Labor, Standard 
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Occupational Classification, 2009) and the 1997 North American Industry Classification 
System (NAICS; United States Department of Labor, North American Industry 
Classification System, 2009).
Using the CATI data, exposure classification was conducted independently by two industrial 
hygienists (raters), blinded to case and control status. The raters’ experience in industrial 
hygiene monitoring ranged from 17 to 27 years; each also had at least 10 years of experience 
in retrospective exposure assessment and participated in a training session prior to reviewing 
the job histories (Rocheleau et al., 2011). This expert review strategy was based on an 
approach that was developed previously and used in the Baltimore-Washington Infant Study 
(Jackson et al., 2004; Correa et al., 2006). For jobs considered possibly exposed to PAHs, 
the industrial hygienists assigned these characteristics: (1) whether inhalation exposure was 
direct, indirect, or both; (2) whether the inhalation exposure was continuous, intermittent, or 
both; (3) the fraction of total hours worked when exposure was direct (fdirect); (4) the 
fraction of total hours worked when exposure was indirect (findirect); (5) the intensity of any 
direct inhalation exposure (on an ordinal scale from 0 to 4; Idirect) during the period of direct 
exposure; (6) the intensity of any indirect inhalation exposure (same scale, Iindirect) during 
the period of indirect exposure. Two raters independently assigned each of these 
characteristics; any jobs on which the raters did not have perfect agreement (i.e. discordant 
jobs) were reviewed at a consensus conference. During the consensus conference, the two 
raters plus a third industrial hygienist discussed each discordant job and reached an 
agreement about the appropriate final rating.
The direct and indirect intensity scores were mapped to intensity values of: <0.1 μg/m3, 1 
μg/m3, 8 μg/m3, and >10 μg/m3. For the purposes of this study, the background intensity of 
occupational PAH exposure was assumed to be zero. A weighted intensity score (Iw) was 
computed from the intensity and frequency as:
Although the exposure assessment was done for all jobs from 3 months before conception 
through the end of the pregnancy, for this study the analysis was restricted to jobs held from 
1 month before conception through the end of the first trimester, as this corresponds to 
relevant periods for the formation of neural tube defects (Selevan et al., 2000). To combine 
weighted intensity with frequency and duration, cumulative PAH exposure during this period 
was calculated as:
The resulting cumulative exposure value was specific for each job held by each woman; a 
woman's total occupational PAH exposure during the critical period was calculated as the 
sum of the job-specific cumulative exposures in the critical period. Occupational exposure 
refers here to inhalation exposures inherent in the job or work-place aside from secondhand 
smoke, and does not consider exposure through skin or ingestion.
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A woman was classified as exposed if her total cumulative occupational PAH exposure in 
the critical period was more than zero (i.e., if one or more of her jobs held during the critical 
period was rated as exposed, whether part-time or full-time jobs). She was considered 
unexposed if her jobs had a cumulative exposure during the critical period of zero (i.e., if all 
her jobs held during the critical period were considered unexposed). Women whose 
occupational PAH exposure could not be assigned for one or more of the jobs held during 
the critical period were excluded. Other sources of potential PAH exposure included 
maternal smoking, secondhand smoke at home, and secondhand smoke at work (all obtained 
from the CATI).
Covariates
Several covariates were considered as potential confounders based on associations with 
NTDs or with PAH exposure as reported in the literature. The CATI yielded data on the 
following maternal characteristics (categories shown in Table 1): age at delivery, race or 
ethnicity, education, number of previous live births, pre-pregnancy body mass index (BMI; 
categorized according to the National Heart, Lung, and Blood Institute cutoffs as 
underweight [<18.5 kg/m2], normal weight [18.5–24.9 kg/m2], overweight [25.0–29.9 kg/
m2], and obese [≥30.0 kg/m2]); preexisting diabetes, and plurality of the index pregnancy. 
Data on the following maternal characteristics pertained to exposure in the periconceptional 
period: use of folate antagonist medications, consumption of folic acid supplements, 
cigarette smoking, secondhand smoke exposure at home, secondhand smoke exposure at 
work, and consumption of alcohol. Also considered as potential covariates were: infant sex, 
annual household income, family history of NTDs, and study site. In the analysis, all 
covariates were treated as categorical variables.
Statistical Analysis
Crude odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for each 
characteristic and NTDs. Frequency distributions of the 23 SOC major job groups were 
tabulated for cases and controls, stratified by occupational PAH exposure status.
Unconditional logistic regression was used to calculate crude and adjusted ORs and 95% CIs 
to evaluate the association of maternal occupational exposure to PAHs with risk of NTDs in 
offspring. Outcomes of interest were individual NTD phenotypes (e.g., anencephaly) and all 
NTDs combined. Covariates were retained in the final models if inclusion resulted in a 
change of 10% or greater in the estimate of effect between maternal occupational exposure 
to PAHs and the risk of NTDs.
Several subanalyses were conducted for combined NTDs and spina bifida, but not 
anencephaly and encephalocele because case numbers were insufficient. To evaluate the 
independent effect of occupational PAH exposure, the first subanalysis controlled for 
exposure to any nonoccupational source of PAHs (i.e., smoking and secondhand smoke 
exposure at home or at work 1 month before conception to 3 months after), whether or not 
those variables met the 10% change in effect criterion for confounding. Effect measure 
modification was examined using the Breslow-Day test for homogeneity of ORs in mothers 
who actively smoked versus those who did not, and in mothers with any smoking exposure 
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(active or secondhand at home or work) versus those who had none. An analysis looked 
more deeply at the effect of occupational PAH exposure in that last stratum (i.e., women 
who were unexposed to any nonoccupational PAH). Subjects were stratified by BMI into 
mothers who were normal or underweight versus obese or overweight, because body fat may 
influence the storage and transformation of PAHs (Agency for Toxic Substances and Disease 
Registry, 1995). Lastly, in an analysis for dose response, the cumulative exposure level was 
categorized into none, low, and high based on the frequency distribution among exposed 
controls, and the two-sided Cochrane-Armitage trend test was used to test for trend.
RESULTS
Participation was 69% among control mothers and 70% among case mothers. Six women 
who could not be assigned PAH exposure status were excluded. For the resulting analysis, 
there were 2989 controls, of whom 3.5% were classified as occupationally exposed to PAHs. 
There were 520 cases of NTDs (5.0% exposed): 136 cases of anencephaly (3.7% exposed), 
321 spina bifida (5.9% exposed), and 63 encephalocele (3.2% exposed).
Risk of NTDs among offspring was higher among mothers who were 25 to 29 years old, 
Hispanic, obese, had a lower education level, more previous live births, or a lower household 
income (Table 1). Risk was also higher among mothers who were exposed to secondhand 
smoke at home or work or who used folate antagonist medications (trimethotrexate, 
trimetrexate, methotrexate, carbamazepine, valproic acid, and phenytoin). Risk of NTDs was 
lower among mothers with singleton pregnancies and those who reported drinking alcohol. 
Relative to a single study site (Arkansas), risk varied across sites.
Prevalence of occupational PAH exposure was higher (p < 0.05) among mothers who were 
Hispanic, overweight or obese, had a lower education level or household income, drank 
alcohol, smoked, or were exposed to secondhand smoke (data not shown).
The distribution of SOC major job groups was similar among the 26 case mothers and 106 
control mothers occupationally exposed to PAHs (Table 2). The largest category was “food 
preparation and serving related” jobs, followed by “sales and related” jobs. Combining those 
two occupations accounted for 81% of exposed case mothers and 77% of exposed control 
mothers. The occupational settings in which most exposed case and control mothers worked 
were restaurants, particularly fast food chains. The most common job duty mentioned by 
exposed mothers was cooking or food preparation.
The crude OR for occupational PAH exposure and any NTD was 1.43 (95% CI, 0.92–2.22) 
and the OR was reduced to approximately 1.00 after adjusting for BMI, secondhand smoke 
at home, and study center (the most parsimonious model, Table 3). The crude OR for spina 
bifida was 1.71 (95% CI, 1.03–2.83), but decreased to 1.21 (95% CI, 0.69–2.11) upon 
adjustment for maternal BMI and education. The ORs for anencephaly and encephalocele 
were consistent with no association or were not estimated because of too few exposed cases 
(<5).
The first subanalysis controlled only for smoking or secondhand smoke at home or work. 
The resulting ORs for occupational PAH exposure were between the crude and parsimonious 
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model results for both NTDs and spina bifida, and were not statistically significant (Table 3). 
Controlling for all smoking exposures together with other covariates in the original 
parsimonious models resulted in nonsignificant ORs similar to the parsimonious models.
There was no evidence of interaction with smoking status. For example, comparing the NTD 
OR for smokers (1.51; 95% CI, 0.90–2.53) with nonsmokers (1.31; 95% CI, 0.57–3.05) 
yielded a p value for homogeneity of 0.78; for spina bifida, the corresponding ORs (1.86; 
95% CI, 1.03–3.34) and 1.40 (95% CI, 0.53–3.71) had a p value for homogeneity of 0.63 
(data not shown). Similar results were found when stratifying by any smoking exposure 
(smoking, secondhand smoke at home or work) versus no smoking exposure. In these 
analyses for interaction, the smallest number of cases in a cell was 5 for smokers who had 
occupational PAH exposure and were mothers of children with spina bifida.
When limiting the analysis to subjects who were not exposed to smoking or secondhand 
smoke at home or work, the crude OR (cOR) for NTDs was 1.28 (95% CI, 0.59–2.75) and 
the adjusted OR (aOR) was 0.69 (95% CI, 0.26–1.80). The cOR for spina bifida was 1.87 
(95% CI, 0.83–4.24) and the aOR was 0.98 (0.37–2.60). In other words, these ORs were not 
substantially different than the original results with the entire subject pool.
When stratified by BMI, the cOR was significantly higher for normal and underweight 
mothers than for overweight or obese mothers, for NTDs (p for homogeneity < 0.03) and 
spina bifida (p < 0.01; Table 4). In particular, the cOR for spina bifida was 3.13 (95% CI, 
1.63–6.03). This OR was slightly attenuated but still statistically significant after adjustment 
for education (aOR, 2.59; 95% CI, 1.32–5.07).
In the analysis of exposure-response relationships, crude risk of combined NTDs did not 
show a statistically significant monotonic trend by the Cochrane-Armitage test. However, 
mothers in the highest exposure category had a cOR of 1.95 (1.11–3.40) compared to no 
PAH exposure (Table 5). After adjustment for covariates, the trend was attenuated and the 
OR for the highest exposure category was 1.30 (95% CI, 0.69–2.44). Spina bifida showed a 
significant crude dose-response trend, where the highest exposure category had an OR of 
2.43 (95% CI, 1.31–4.53), but risk was attenuated to 1.73 (95% CI, 0.87–3.42) after 
adjustment and the trend lost significance.
DISCUSSION
The crude results of this study suggested a positive association between maternal 
occupational exposure to PAHs and risk of NTDs, particularly spina bifida, in offspring. 
However, after adjustment, the ORs for NTDs and spina bifida were attenuated and no 
longer significant; therefore, the association might have been largely due to confounding. 
Similarly, risk of spina bifida in offspring increased with increasing cumulative exposure in 
the crude estimates, but not the adjusted estimates. The only statistically significant 
associations after adjustment for confounding were observed among women who were 
underweight or normal weight.
These observations are generally inconclusive and as such neither support nor refute the 
literature. Experiments report that PAHs cause NTDs in laboratory animals (Faustman-Watts 
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et al., 1984; Barbieri et al., 1986; Stark et al., 1989; Incardona et al., 2004). Human 
populations with likely environmental exposures had elevated risk of NTDs in Canadian 
areas near large-scale coke oven operations, (adjusted relative risk, 1.25; 95% CI, 1.04–1.51; 
Dodds and Seviour, 2001) and nervous system anomalies were higher in regions in the 
United Kingdom exposed to total black smoke (OR, 1.10 per increase of 1000 μg/m3, 95% 
CI, 1.03–1.18; Rankin et al., 2009). Most importantly, one human study of biomarkers of 
exposure (cumulative from all sources) reported that high maternal blood PAH conferred an 
8.70-fold risk of NTDs (95% CI, 2.02–37.04; Naufal et al., 2010) and another that high 
placental concentrations were associated with a 4.52-fold increased risk (95% CI, 2.20–9.74; 
Ren et al., 2011). The lower estimates of risk in the present analysis could have been due to 
(1) the less accurate measurement of exposure based on a retrospective exposure assessment 
of interview data instead of on biologic markers, (2) the focus on occupational exposures 
alone instead of cumulative exposure from all sources, and (3) the higher PAH exposures 
experienced by some rural Chinese populations such as the one used in both the Naufal and 
Ren studies (Naufal et al., 2010; Ren et al., 2011), who use coal for home heating and 
cooking (Naufal et al., 2010) or are exposed to high ambient PAH emissions from coal 
production (Zhang et al., 2009).
PAHs are known to cross the placenta (Gladen et al., 2000) and have been found in cord 
blood (Madhavan and Naidu, 1995). They have been shown to form bulky DNA adducts in 
mothers and offspring (Topinka et al., 2009). Workers exposed to PAHs have higher levels of 
PAH-DNA adducts compared with the general population (Perera et al., 1994; Brandt and 
Watson, 2003). If not repaired, these adducts can disrupt the cell's microenvironment, 
leading to inhibition of important enzymes, cell death, and alteration of other cells (Agency 
for Toxic Substances and Disease Registry, 1995; Choi et al., 2008). Because PAHs are 
highly lipophilic and tend to be stored mostly in kidneys, liver, and fat (Agency for Toxic 
Substances and Disease Registry, 1995), they could become sequestered in fat stores in 
overweight or obese women, resulting in lower exposure to the fetus. That observation was 
consistent with the results from the current study.
The major limitation of this study was potential exposure misclassification. Although 
industrial hygienists had the knowledge and experience to assign PAH exposure based on 
maternal job history, there is a possibility for inaccurate assessment. However, this approach 
was superior to a strategy that relies completely on maternal self-report, in which knowledge 
of PAH exposure is likely to be limited (Olsson et al., 2010). Similarly, the NBDPS did not 
collect information about the use of local exhaust ventilation and personal protective 
equipment; those were estimated by the industrial hygienists when evaluating each job. 
Many of the case and control mothers reported working in restaurants, especially fast food 
establishments; the exposure assessment focused on inhalation exposures and did not assess 
PAH exposure owing to consumption of food prepared at high temperatures. Information 
was lacking on other environmental sources of PAHs, although occupational exposures are 
generally higher than those found in the environment (Brandt and Watson, 2003; Hansen et 
al., 2008). Secondhand smoke exposure at home and especially at work may have been 
inaccurately reported in the CATI, though both showed increased risk of NTDs in our data. 
Exposure biomarkers such as those used in studies of rural Chinese populations (Naufal et 
al., 2010; Ren et al., 2011) are generally superior to the interview data used in this study, in 
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accuracy and in their measurement of cumulative exposure from all sources, occupational or 
otherwise. One potential drawback is that bio-markers collected at birth might not accurately 
reflect the mother's exposure during the critical period of fetal development. In addition, by 
focusing on PAHs from occupational exposures instead of from all sources, the current study 
examined consequences of some of the highest exposure levels humans are likely to 
encounter (Brandt and Watson, 2003; Hansen et al., 2008), and was potentially more 
relevant to any focused public health intervention. Despite the fact that the NBDPS is one of 
the largest population-based case-control studies of the causes of birth defects to date, the 
statistical power of the present study was hindered by the small number of exposed subjects, 
leading to a lack of precision. For example, the OR for spina bifida remained elevated (1.73) 
but with a wide 95% CI (0.87–3.42) for the highest cumulative exposure category after 
adjustment for covariates; this result might have been more conclusive with more subjects. 
Although adjustment was made for many important maternal factors, there is the potential 
for confounding by unidentified or unmeasured factors.
The use of NBDPS data is one of the strengths of this study. It has an extensive occupational 
exposure database. The case-control study design is more practical than occupational cohort 
studies for rare outcomes such as birth defects. It yielded data on potentially important 
confounding factors, such as BMI and smoking. The extensive case classification by NBDPS 
clinical geneticists produced accurate and fairly homogeneous case groups for analysis.
Although generally inconclusive, this study suggests that underweight or normal weight 
women exposed to occupational PAHs have a greater risk of spina bifida in offspring than 
similar women who are not exposed. Future investigations of PAHs and NTDs may benefit 
from stratification by maternal obesity, gathering detailed data on other factors affecting risk 
of NTDs, additional measures of exposure such as biomarker data, and gathering 
information on maternal and fetal genotypes related to PAH metabolism (Wassenberg et al., 
2005; Shimada, 2006).
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Table 1





a % OR (95% CI)
Total 2989 520
Age (years)
<20 330 11.0 64 12.5 0.96 (0.70–1.31)
20–24 678 22.7 119 22.8 0.87 (0.67–1.12)
25–29 (referent) 819 27.4 166 31.9 1.00
30–34 795 26.6 102 19.6 0.63 (0.49–0.83)
≥35 367 12.3 69 13.3 0.93 (0.68–1.26)
Race/Ethnicity
White non-Hispanic (referent) 1939 68.2 309 62.7 1.00
Black non-Hispanic 377 13.3 59 12.0 0.98 (0.73–1.33)
Hispanic 527 18.5 125 25.3 1.49 (1.18–1.87)
Other 139 4.7 27 5.2 1.22 (0.79–1.87)
Education (years)
<12 295 9.9 75 14.4 1.73 (1.30–2.29)
12 741 24.8 158 30.4 1.45 (1.17–1.79)
>12 (referent) 1951 65.3 287 55.2 1.00
Number of previous live births
0 (referent) 1327 44.4 195 37.5 1.00
1 1038 34.7 190 36.5 1.25 (1.00–1.54)
≥2 623 20.8 135 26.0 1.47 (1.16–1.87)
Pre-Pregnancy BMI
Under weight 152 5.2 18 3.6 0.77 (0.47–1.28)
Normal weight (referent) 1675 57.2 256 51.0 1.00
Over weight 663 22.6 106 21.1 1.05 (0.82–1.33)
Obese 438 15.0 122 24.3 1.82 (1.43–2.32)
Preexisting diabetes
Yes (Type 1 and 2) 15 0.5 5 1.0 1.92 (0.70–5.32)
No (referent) 2974 99.5 515 99.0 1.00
Plurality
1 (referent) 2892 96.8 492 94.6 1.00
>2 95 3.2 24 5.4 1.73 (1.12–2.67)
Infant sex
Male 1492 49.9 237 48.3 1.07 (0.88–1.29)
Female (referent) 1495 50.1 254 51.7 1.00
Folate antagonist medication
b,c
Yes 28 0.9 10 1.9 2.07 (1.00–4.30)

















a % OR (95% CI)
No (referent) 2957 99.1 509 98.1 1.00
Folic acid supplements
b
Yes 2612 87.4 442 85.0 0.82 (0.63–1.07)
No (referent) 377 12.6 78 15.0 1.00
Cigarette smoking
b
Yes 615 20.6 98 18.8 0.90 (0.71–1.14)
No (referent) 2374 79.4 423 81.2 1.00
Secondhand smoking at home
b
Yes 534 17.9 118 22.7 1.35 (1.08–1.69)
No (referent) 2455 82.1 402 77.3 1.00
Secondhand smoking at work
b
Yes 571 19.1 137 26.4 1.51 (1.22–1.88)
No (referent) 2418 80.9 383 73.6 1.00
Alcohol drinking
b
Yes 1318 44.3 192 37.1 0.74 (0.61–0.90)
No (referent) 1660 55.7 326 62.9 1.00
Annual household income ($)
<20,000 683 25.8 157 32.8 1.71 (1.34–2.19)
20–49,999 909 34.3 179 37.5 1.47 (1.16–1.86)
≥50,000 (referent) 1059 39.9 142 29.7 1.00
1st-generation family history of NTDs
Yes 5 0.2 3 0.6 3.46 (0.82–14.53)
No (referent) 2984 99.8 517 99.4 1.00
Study center
Arkansas (referent) 373 12.5 88 16.9 1.00
California 349 11.7 85 16.3 1.03 (0.74–1.44)
Iowa 413 13.8 85 16.3 0.87 (0.63–1.21)
Massachusetts 429 14.3 36 6.9 0.36 (0.24–0.54)
New Jersey 415 13.9 48 9.2 0.49 (0.34–0.72)
New York 340 11.4 44 8.5 0.55 (0.37–0.81)
Texas 319 10.7 73 14.0 0.97 (0.69–1.37)
CDC/Atlanta 351 11.7 61 11.7 0.74 (0.52–1.05)
OR, odds ratio; CI, confidence interval; BMI, body mass index; NTD, neural tube defect; CDC, Centers for Disease Control and Prevention.
a
Sum may not add up to total because of missing values.
b
Exposure 1 month before conception to 3 months after.
c
Please see text for a list of medications included.
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Table 2
Standard Occupation Code Major Job Groups
a
 for Jobs of Mothers of Neural Tube Defect Cases and Controls 
by Occupational Polycyclic Aromatic Hydrocarbon Exposure Status, National Birth Defects Prevention Study, 
1997–2002
Cases Controls
Exposed Unexposed Exposed Unexposed
Major group n
b
 = 26 % n = 494 % n = 106 % n = 2883 %
Management 0 46 7.3 3 2.8 319 9.3
Business and financial operations 0 26 4.1 0 148 4.3
Computer and mathematical 0 5 0.8 0 52 1.5
Architecture and engineering 0 1 0.2 1 0.9 11 0.3
Life, physical, and social science 0 6 1.0 0 43 1.3
Community and social services 0 10 1.6 0 68 2.0
Legal 0 6 1.0 0 33 1.0
Education, training, and library 0 34 5.4 0 291 8.5
Arts, design, entertainment, sports and media 0 10 1.6 0 50 1.5
Healthcare practitioners and technical 0 48 7.6 0 275 8.0
Healthcare support 0 31 4.9 1 0.9 167 4.9
Protective service 0 4 0.6 0 25 0.7
Food preparation and serving related 13 50.0 50 7.7 52 47.7 230 6.7
Building and grounds cleaning and maintenance 0 29 4.6 1 0.9 73 2.1
Personal care and service 0 31 4.9 7 6.4 157 4.6
Sales and related 8 30.8 92 14.7 32 29.4 443 13.0
Office and administrative support 0 125 19.9 0 745 21.8
Farming, fishing and forestry 1 3.9 20 3.2 2 1.8 49 1.4
Construction and extraction 0 2 0.3 0 5 0.2
Installation, maintenance and repair 0 2 0.3 1 0.9 5 0.2
Production 2 7.7 34 5.4 6 5.5 151 4.4
Transportation and material moving 1 3.9 15 2.4 3 2.8 77 2.3
Military specific 1 3.9 1 0.2 0 4 0.1
a
Multiple jobs may have been held by individual mothers; 109 case mothers and 484 control mothers had more than one job 1 month before 
conception through 3 months after.
b
Total number of mothers.
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Table 4
Association Between Maternal Occupational Exposure to Polycyclic Aromatic Hydrocarbons and the Risk of 
Any Neural Tube Defect or of Spina Bifida in Offspring, National Birth Defects Prevention Study, 1997–2002
BMI Category Controls Any neural tube defect Spina bifida











Not exposed (referent) 1779 260 1.00 260 1.00 142 1.00 142 1.00
Exposed 48 14 2.00 (1.08–3.67) 14 1.71 (0.91–3.19) 12 3.13 (1.63–6.03) 12 2.59 (1.32–5.07)
Overweight or Obese
Not exposed (referent) 1046 220 1.00 220 1.00 152 1.00 152 1.00
Exposed 55 8 0.69 (0.32–1.47) 8 0.62 (0.29–1.34) 5 0.63 (0.23–1.59) 5 0.60 (0.23–1.54)
BMI, body mass index; PAH, polycyclic aromatic hydrocarbon; OR, odds ratio; CI, confidence interval.
a
Adjusted for secondhand smoking at home and study center.
b
Adjusted for education.
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Table 5
Association Between Cumulative Maternal Occupational Exposure
a
 to Polycyclic Aromatic Hydrocarbons and 
the Risk of Any Neural Tube Defect or of Spina Bifida in Offspring, National Birth Defects Prevention Study, 
1997–2002
Controls Any Neural Tube Defect Spina Bifida










None 2883 494 1.00 (referent) 480 1.00 (referent) 302 1.00 (referent) 294 1.00 (referent)
Low (0.32–100 μg/m3-hr)
d 55 9 0.96 (0.47–1.95) 9 0.82 (0.40–1.68) 6 1.20 (0.37–3.89) 6 0.85 (0.36–2.01)
High (108-3800 ug/m3-hr) 51 17 1.95 (1.11–3.40) 13 1.30 (0.69–2.44) 13 2.43 (1.31–4.53) 11 1.73 (0.87–3.42)
PAH, polycyclic aromatic hydrocarbon; OR, odds ratio; CI, confidence interval; BMI, body mass index.
a
Cumulative PAH exposure during this period was calculated as: (Weighted intensity in mg/hr) × [(Exposure frequency in hr/week) / (40 hr/week)] 
× [(Hours worked per week) / (7 days per week)] × (Number of days worked in the critical period). Please see Materials and Methods.
b
Adjusted for BMI, secondhand smoking at home, and study center.
c
Adjusted for BMI and education.
d
Low versus high based on median value of cumulative PAH exposure among the controls.
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